Signal transduction of platelet-induced liver regeneration and decrease of liver fibrosis

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 5412-5425

  Murata, Soichiro ^a   Maruyama, Takehito ^a   Nowatari, Takeshi ^a   Takahashi, Kazuhiro ^a   Ohkohchi, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Adenosine; Akt; Cyclic AMP; ERK1 2; Platelet; S1p; STAT3

Indexed keywords

CYCLIC AMP; CYCLINE; ELTROMBOPAG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL XL; PROTEIN KINASE B; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; ROMIPLOSTIM; SCATTER FACTOR; SOMATOMEDIN C; STAT3 PROTEIN; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ADENOSINE; IL6 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN, HUMAN;

CHOLESTASIS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; ISCHEMIA; KUPFFER CELL; LIVER CELL; LIVER FIBROSIS; LIVER REGENERATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; THROMBOCYTE; THROMBOCYTOPENIA; VIRUS HEPATITIS; ANIMAL; BIOSYNTHESIS; ENZYME ACTIVATION; LIVER CIRRHOSIS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY;

ADENOSINE; ANIMALS; BLOOD PLATELETS; CYCLIC AMP; ENDOTHELIAL CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; INTERLEUKIN-6; LIVER CIRRHOSIS; LIVER REGENERATION; MICE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; THROMBOPOIETIN;

EID: 84897402864     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15045412     Document Type: Review

References (96)

1. Popper, H. Pathologic aspects of cirrhosis. A review. Am. J. Pathol. 1977, 87, 228-264.
2. Poordad, F. Review article: Thrombocytopenia in chronic liver disease. Aliment. Pharmacol. Ther. 2007, 26, S5-S11.
3. Afdhal, N.; McHutchison, J.; Brown, R.; Jacobson, I.; Manns, M.; Poordad, F.; Weksler, B.; Esteban, R. Thrombocytopenia associated with chronic liver disease. J. Hepatol. 2008, 48, 1000-1007.
4. Witters, P.; Freson, K.; Verslype, C.; Peerlinck, K.; Hoylaerts, M.; Nevens, F.; van Geet, C.; Cassiman, D. Review article: Blood platelet number and function in chronic liver disease and cirrhosis. Aliment. Pharmacol. Ther. 2008, 27, 1017-1029.
5. Bashour, F.N.; Teran, J.C.; Mullen, K.D. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am. J. Gastroenterol. 2000, 95, 2936-2939.
6. Merion, R.M.; Schaubel, D.E.; Dykstra, D.M.; Freeman, R.B.; Port, F.K.; Wolfe, R.A. The survival benefit of liver transplantation. Am. J. Transplant. 2005, 5, 307-313.
7. Neuberger, J.; James, O. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet 1999, 354, 1636-1639.
8. Guarrera, J.V.; Emond, J.C. Advances in segmental liver transplantation: Can we solve the donor shortage? Transplant. Proc. 2001, 33, 3451-3455.
9. Taylor, M.C.; Grieg, P.D.; Detsky, A.S.; McLeod, R.S.; Abdoh, A.; Krahn, M.D. Factors associated with the high cost of liver transplantation in adults. Can. J. Surg. 2002, 45, 425-434.
10. Mueller, A.R.; Platz, K.P.; Kremer, B. Early postoperative complications following liver transplantation. Best Pract. Res. Clin. Gastroenterol. 2004, 18, 881-900.
11. Porrett, P.M.; Hsu, J.; Shaked, A. Late surgical complications following liver transplantation. Liver Transplant. 2009, 15, S12-S18.
12. Chang, Y.; Bluteau, D.; Debili, N.; Vainchenker, W. From hematopoietic stem cells to platelets. J. Thromb. Haemost. 2007, 5, S318-S327.
13. Suzuki, H.; Yamazaki, H.; Tanoue, K. Immunocytochemical aspects of platelet adhesive proteins and membrane glycoproteins during activation. Prog. Histochem. Cytochem. 1996, 30, 1-106.
14. Blair, P.; Flaumenhaft, R. Platelet α-granules: Basic biology and clinical correlates. Blood Rev. 2009, 23, 177-189.
15. McNicol, A.; Israels, S.J. Platelet dense granules: Structure, function and implications for haemostasis. Thromb. Res. 1999, 95, 1-18.
16. Polasek, J. Platelet secretory granules or secretory lysosomes? Platelets 2005, 16, 500-501.
17. Holmsen, H. Physiological functions of platelets. Ann. Med. 1989, 21, 23-30.
18. Broos, K.; Feys, H.B.; de Meyer, S.F.; Vanhoorelbeke, K.; Deckmyn, H. Platelets at work in primary hemostasis. Blood Rev. 2011, 25, 155-167.
19. Suzuki, H.; Nakamura, S.; Itoh, Y.; Tanaka, T.; Yamazaki, H.; Tanoue, K. Immunocytochemical evidence for the translocation of alpha granule membrane glycoprotein IIb/IIIa (integrin alpha IIb beta 3) of human platelets to the surface membrane during the release reaction. Histochemistry 1992, 97, 381-388.
20. Mazzucco, L.; Borzini, P.; Gope, R. Platelet-derived factors involved in tissue repair-from signal to function. Transfus. Med. Rev. 2010, 24, 218-234.
21. Ranzato, E.; Balbo, V.; Boccafoschi, F.; Mazzucco, L.; Burlando, B. Scratch wound closure of C2C12 mouse myoblasts is enhanced by human platelet lysate. Cell Biol. Int. 2009, 33, 911-917.
22. Rozman, P.; Bolta, Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol. Alp. Panon. Adriat. 2007, 16, 156-165.
23. Yamaguchi, R.; Terashima, H.; Yoneyama, S.; Tadano, S.; Ohkohchi, N. Effects of platelet-rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor. J. Surg. Res. 2012, 173, 258-266.
24. Radice, F.; Yánez, R.; Gutiérrez, V.; Rosales, J.; Pinedo, M.; Coda, S. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet derived growth factors. Arthroscopy 2010, 26, 50-57.
25. Dugrillon, A.; Eichler, H.; Kern, S.; Klüter, H. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int. J. Oral Maxillofac. Surg. 2002, 31, 615-619.
26. Hartmann, E.K.; Heintel, T.; Morrison, R.H.; Weckbach, A. Influence of platelet-rich plasma on the anterior fusion in spinal injuries: A qualitative and quantitative analysis using computer tomography. Arch. Orthop. Trauma Surg. 2010, 130, 909-914.
27. De Vos, R.J.; Weir, A.; van Schie, H.T.; Bierma-Zeinstra, S.M.; Verhaar, J.A.; Weinans, H.; Tol, J.L. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 2010, 303, 144-149.
28. Rodeo, S.A.; Delos, D.; Weber, A.; Ju, X.; Cunningham, M.E.; Fortier, L.; Maher, S. What's new in orthopaedic research. J. Bone Jt. Surg. Am. 2010, 92, 2491-2501.
29. Nocito, A.; Georgiev, P.; Dahm, F.; Jochum, W.; Bader, M.; Graf, R.; Clavien, P.A. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 2007, 45, 369-376.
30. McNicol, A.; Israels, S.J. Beyond hemostasis: The role of platelets in inflammation, malignancy and infection. Cardiovasc. Hematol. Disord. Drug Targets 2008, 8, 99-117.
31. Mehta, P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood 1984, 63, 55-63.
32. Nash, G.F.; Turner, L.F.; Scully, M.F.; Kakkar, A.K. Platelets and cancer. Lancet Oncol. 2002, 3, 425-430.
33. Elzey, B.D.; Sprague, D.L.; Ratliff, T.L. The emerging role of platelets in adaptive immunity. Cell. Immunol. 2005, 238, 1-9.
34. Sowa, J.M.; Crist, S.A.; Ratliff, T.L.; Elzey, B.D. Platelet influence on T-and B-cell responses. Arch. Immunol. Ther. Exp. 2009, 57, 235-241.
35. Klinger, M.H.; Jelkmann, W. Role of blood platelets in infection and inflammation. J. Interf. Cytokine Res. 2002, 22, 913-922.
36. Sprague, D.L.; Elzey, B.D.; Crist, S.A.; Waldschmidt, T.J.; Jensen, R.J.; Ratliff, T.L. Platelet-mediated modulation of adaptive immunity: Unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008, 111, 5028-5036.
37. + T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 2006, 43, 306-315.
38. Khandoga, A.; Biberthaler, P.; Messmer, K.; Krombach, F. Platelet-endothelial cell interactions during hepatic ischemia-reperfusion in vivo: A systematic analysis. Microvasc. Res. 2003, 65, 71-77.
39. Pak, S.; Kondo, T.; Nakano, Y.; Murata, S.; Fukunaga, K.; Oda, T.; Sasaki, R.; Ohkohchi, N. Platelet adhesion in the sinusoid caused hepatic injury by neutrophils after hepatic ischemia reperfusion. Platelets 2010, 21, 282-288.
40. Nakano, Y.; Kondo, T.; Matsuo, R.; Hashimoto, I.; Kawasaki, T.; Kohno, K.; Myronovych, A.; Tadano, S.; Hisakura, K.; Ikeda, O.; et al. Platelet dynamics in the early phase of postischemic liver in vivo. J. Surg. Res. 2008, 149, 192-198.
41. Zaldivar, M.M.; Pauels, K.; von Hundelshausen, P.; Berres, M.L.; Schmitz, P.; Bornemann, J.; Kowalska, M.A.; Gassler, N.; Streetz, K.L.; Weiskirchen, R.; et al. CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology 2010, 51, 1345-1353.
42. Laschke, M.W.; Dold, S.; Menger, M.D.; Jeppsson, B.; Thoelacius, H. Platelet-dependent accumulation of leukocytes in sinusoids mediates hepatocellular damage in bile duct ligation-induced cholestasis. Br. J. Pharmacol. 2008, 153, 148-156.
43. Lang, P.A.; Contalado, C.; Gergiev, P.; El-Bardy, A.M.; Recher, M.; Kurrer, M.; Cervantes-Barragan, L.; Ludewig, B.; Calzascia, T.; Bolinger, B.; et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat. Med. 2008, 14, 756-761.
44. Murata, S.; Ohkohchi, N.; Matsuo, R.; Ikeda, O.; Myronovych, A.; Hoshi, R. Platelets promote liver regeneration in early period after hepatectomy in mice. World J. Surg. 2007, 31, 808-816.
45. Lesurtel, M.; Graf, R.; Aleil, B.; Walther, D.J.; Tian, Y.; Jochum, W.; Gachet, C.; Bader, M.; Clavien, P.A. Platelet-derived serotonin mediates liver regeneration. Science 2006, 312, 104-107.
46. Wolber, E.M.; Jelkmann, W. Thrombopoietin: The novel hepatic hormone. News Physiol. Sci. 2002, 17, 6-10.
47. Cheng, G. Eltrombopag, a thrombopoietin-receptor agonist in the treatment of adult chronic immune thrombocytopenia: A review of the efficacy and safety profile. Ther. Adv. Hematol. 2012, 3, 155-164.
48. Murata, S.; Matsuo, R.; Ikeda, O.; Myronovych, A.; Watanabe, M.; Hisakura, K.; Nakano, Y.; Hashimoto, I.; Ohkohchi, N. Platelets promote liver regeneration under conditions of kupffer cell depletion after hepatectomy in mice. World J. Surg. 2008, 32, 1088-1096.
49. Myronovych, A.; Murata, S.; Chiba, M.; Matsuo, R.; Ikeda, O.; Watanabe, M.; Hisakura, K.; Nakano, Y.; Kohno, K.; Kawasaki, T.; et al. Role of platelets on liver regeneration after 90% hepatectomy in mice. J. Hepatol. 2008, 49, 363-372.
50. Matsuo, R.; Nakano, Y.; Ohkohchi, N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann. Surg. 2011, 253, 759-763.
51. Murata, S.; Hashimoto, I.; Nakano, Y.; Myronovych, A.; Watanabe, M.; Ohkohchi, N. Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann. Surg. 2008, 248, 821-828.
52. Hisakura, K.; Murata, S.; Fukunaga, K.; Myronovych, A.; Tadano, S.; Kawasaki, T.; Kohno, K.; Kobayashi, E.; Saito, T.; Yasue, H.; et al. Platelets prevent acute liver damage after extended hepatectomy in pigs. J. Hepatobiliary Pancreat. Sci. 2010, 17, 855-864.
53. Hisakura, K.; Murata, S.; Takahashi, K.; Matsuo, R.; Pak, S.; Ikeda, N.; Kawasaki, T.; Kohno, K.; Myronovych, A.; Nakano, Y.; et al. Platelets prevent acute hepatitis induced by anti-Fas antibody. J. Gastroenterol. Hepatol. 2011, 26, 348-355.
54. Braet, F.; Wisse, E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: A review. Comp. Hepatol. 2002, 23, 1:1-17.
55. Wack, K.E.; Ross, M.A.; Zegarra, V.; Sysko, L.R.; Watkins, S.C.; Stolz, D.B. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology 2001, 33, 363-378.
56. Nakamura, M.; Shibasaki, M.; Nitta, Y.; Endo, Y. Translocation of platelets into Disse space and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumour necrosis factor: The role of Kupffer cells. J. Hepatol. 1998, 28, 991-999.
57. Endo, Y.; Nakamura, M. The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br. J. Pharmacol. 1992, 105, 613-619.
58. Ohtaki, Y.; Shimauchi, H.; Yokochi, T.; Endo, Y. In vivo platelet response to lipopolysaccharide in mice: Proposed method for evaluating new antiplatelet drugs. Thromb. Res. 2003, 108, 303-309.
59. Nakamura, T.; Nishizawa, T.; Hagiya, M.; Seki, T.; Shimonishi, M.; Sugimura, A.; Tashiro, K.; Shimizu, S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342, 440-443.
60. Matsuo, R.; Ohkohchi, N.; Murata, S.; Ikeda, O.; Nakano, Y.; Watanabe, M.; Hisakura, K.; Myronovych, A.; Kubota, T.; Narimatsu, H.; et al. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J. Surg. Res. 2008, 145, 279-286.
61. Ozaki, M.; Haga, S.; Zhang, H.Q.; Irani, K.; Suzuki, S. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: Role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 2003, 10, 508-515.
62. Conery, A.R.; Cao, Y.; Thompson, E.A.; Townsend, C.M., Jr.; Ko, T.C.; Luo, K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis. Nat. Cell Biol. 2004, 6, 366-372.
63. Pearson, G.; Robinson, F.; Beers Gibson, T.; Xu, B.E.; Karandikar, M.; Berman, K.; Cobb, M.H. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr. Rev. 2001, 22, 153-183.
64. Gauldie, J.; Richards, C.; Baumann, H. IL-6 and the acute phase reaction. Res. Immunol. 1992, 143, 755-759.
65. Montalvo-Jave, E.E.; Escalante-Tattersfield, T.; Ortega-Salgado, J.A.; Piña, E.; Geller, D.A. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J. Surg. Res. 2008, 147, 153-159.
66. Croner, R.S.; Hoerer, E.; Kulu, Y.; Hackert, T.; Gebhard, M.M.; Herfarth, C.; Klar, E. Hepatic platelet and leukocyte adherence during endotoxemia. Crit. Care 2006, 10, R15:1-R15.
67. Kawasaki, T.; Murata, S.; Takahashi, K.; Nozaki, R.; Ohshiro, Y.; Ikeda, N.; Pak, S.; Myronovych, A.; Hisakura, K.; Fukunaga, K.; et al. Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J. Hepatol. 2010, 53, 648-654.
68. Yatomi, Y.; Ohmori, T.; Rile, G.; Kazama, F.; Okamoto, H.; Sano, T.; Satoh, K.; Kume, S.; Tigyi, G.; Igarashi, Y.; et al. Sphingosine-1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 2000, 96, 3431-3438.
69. Takuwa, Y.; Okamoto, Y.; Yoshioka, K.; Takuwa, N. Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system. Biochim. Biophys. Acta 2008, 1781, 483-488.
70. Zheng, D.M.; Kitamura, T.; Ikejima, K.; Enomoto, N.; Yamashina, S.; Suzuki, S.; Takei, Y.; Sato, N. Sphingosine-1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: Role of intracellular calcium and nitric oxide. Hepatology 2006, 44, 1278-1287.
71. Fernández-Pisonero, I.; Dueáas, A.I.; Barreiro, O.; Montero, O.; Sánchez-Madrid, F.; Garcia-Rodriguez, C. Lipopolysaccharide and sphingosine-1-phosphate cooperate to induce inflammatory molecules and leukocyte adhesion in endothelial cells. J. Immunol. 2012, 189, 5402-5410.
72. Bilzer, M.; Roggel, F.; Gerbes, A.L. Role of Kupffer cells in host defense and liver disease. Liver Int. 2006, 26, 1175-1186.
73. Meijer, C.; Wiezer, M.J.; Diehl, A.M.; Schouten, H.J.; Schouten, H.J.; Meijer, S.; van Rooijen, N.; van Lambalgen, A.A.; Dijkstra, C.D.; van Leeuwen, P.A. Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy. Liver 2000, 20, 66-77.
74. Akerman, P.; Cote, P.; Yang, S.Q.; McClain, C.; Nelson, S.; Bagby, G.J.; Diehl, A.M. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 1992, 263, G579-G585.
75. Yamada, Y.; Webber, E.M.; Kirillova, I.; Peschon, J.J.; Fausto, N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor. Hepatology 1998, 28, 959-970.
76. Yamada, Y.; Kirillova, I.; Peschon, J.J.; Fausto, N. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 1997, 94, 1441-1446.
77. Malik, R.; Selden, C.; Hodgson, H. The role of non-parenchymal cells in liver growth. Semin. Cell Dev. Biol. 2002, 13, 425-431.
78. Abshagen, K.; Eipel, C.; Kalff, J.C.; Menger, M.D.; Vollmar, B. Loss of NF-κB activation in Kupffer cell-depleted mice impairs liver regeneration after partial hepatectomy. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G1570-G1577.
79. Takahashi, K.; Kozuma, Y.; Suzuki, H.; Tamura, T.; Maruyama, T.; Fukunaga, K.; Murata, S.; Ohkohchi, N. Human platelets promote liver regeneration with Kupffer cells in SCID mice. J. Surg. Res. 2013, 180, 62-72.
80. Cooper, K.L.; Fitzgerald, P.; Dillingham, K.; Helme, K.; Akehurst, R. Romiplostim and eltrombopag for immune thrombocytopenia: Methods for indirect comparison. Int. J. Technol. Assess. Health Care 2012, 28, 249-258.
81. McHutchison, J.G.; Dusheiko, G.; Shiffman, M.L.; Rodriguez-Torres, M.; Sigal, S.; Bourliere, M.; Berg, T.; Gordon, S.C.; Campbell, F.M.; Theodore, D.; et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N. Engl. J. Med. 2007, 357, 2227-2236.
82. Afdhal, N.H.; Giannini, E.G.; Tayyab, G.; Mohsin, A.; Lee, J.W.; Andriulli, A.; Jeffers, L.; McHutchison, J.; Chen, P.J.; Han, K.H.; et al. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N. Engl. J. Med. 2012, 367, 716-724.
83. Kawaguchi, T.; Komori, A.; Seike, M.; Fujiyama, S.; Watanabe, H.; Tanaka, M.; Sakisaka, S.; Nakamuta, M.; Sasaki, Y.; Oketani, M.; et al. Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: A randomized, open-label, phase II study. J. Gastroenterol. 2012, 47, 1342-1351.
84. Watanabe, M.; Murata, S.; Hashimoto, I.; Nakano, Y.; Ikeda, O.; Aoyagi, Y.; Matsuo, R.; Fukunaga, K.; Yasue, H.; Ohkohchi, N. Platelets contribute to the reduction of liver fibrosis in mice. J. Gastroenterol. Hepatol. 2009, 24, 78-89.
85. Arthur, M.J. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279, G245-G249.
86. Benyon, R.C.; Arthur, M.J. Extracellular matrix degradation and the role of hepatic stellate cells. Semin. Liver Dis. 2001, 21, 373-384.
87. Winwood, P.J.; Schuppan, D.; Iredale, J.P.; Kawser, C.A.; Docherty, A.J.; Arthur, M.J.P. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: Characterization and expression in cultured cells. Hepatology 1995, 22, 304-315.
88. Hemmann, S.; Graf, J.; Roderfeld, M.; Roeb, E. Expression of MMPs and TIMPs in liver fibrosis-A systematic review with special emphasis on anti-fibrotic strategies. J. Hepatol. 2007, 46, 955-975.
89. Kodama, T.; Takehara, T.; Hikita, H.; Shimizu, S.; Li, W.; Miyagi, T.; Hosui, A.; Tatsumi, T.; Ishida, H.; Tadokoro, S.; et al. Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice. Gastroenterology 2010, 138, 2487-2498.
90. Takahashi, K.; Murata, S.; Fukunaga, K.; Ohkohchi, N. Human platelets inhibit liver fibrosis in severe combined immunodeficiency mice. World J. Gastroenterol. 2013, 19, 5250-5260.
91. Maruyama, T.; Murata, S.; Takahashi, K.; Tamura, T.; Nozaki, R.; Ikeda, N.; Fukunaga, K.; Oda, T.; Sasaki, R.; Ohkohchi, N. Platelet transfusion improves liver function in patients with chronic liver disease and cirrhosis. Tohoku J. Exp. Med. 2013, 229, 213-220.
92. Gressner, A.M.; Weiskirchen, R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J. Cell. Biol. Med. 2006, 10, 76-99.
93. Friedman, S.L. The cellular basis of hepatic fibrosis-Mechanisms and treatment strategies. N. Engl. J. Med. 1993, 328, 1828-1835.
94. Friedman, S.L.; Maher, J.J.; Bissell, D.M. Mechanisms and therapy of hepatic fibrosis: Report of the AASLD single topic basic research conference. Hepatology 2000, 32, 1403-1408.
95. Friedman, S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134, 1655-1669.
96. Ikeda, N.; Murata, S.; Maruyama, T.; Tamura, T.; Nozaki, R.; Kawasaki, T.; Fukunaga, K.; Oda, T.; Sasaki, R.; Homma, M.; et al. Platelet-derived adenosine 5'-triphosphate suppresses activation of human hepatic stellate cell: In vitro study. Hepatol. Res. 2012, 42, 91-102.